Flagship Harbor Advisors LLC trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 2.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 10,714 shares of the company’s stock after selling 306 shares during the quarter. Flagship Harbor Advisors LLC’s holdings in Colgate-Palmolive were worth $974,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Toth Financial Advisory Corp raised its position in shares of Colgate-Palmolive by 1.6% during the 4th quarter. Toth Financial Advisory Corp now owns 55,878 shares of the company’s stock worth $5,080,000 after buying an additional 883 shares in the last quarter. CFS Investment Advisory Services LLC raised its holdings in Colgate-Palmolive by 10.1% during the fourth quarter. CFS Investment Advisory Services LLC now owns 13,114 shares of the company’s stock worth $1,192,000 after purchasing an additional 1,203 shares in the last quarter. Grimes & Company Inc. lifted its position in Colgate-Palmolive by 3.4% in the fourth quarter. Grimes & Company Inc. now owns 12,503 shares of the company’s stock worth $1,137,000 after purchasing an additional 410 shares during the period. Lantz Financial LLC boosted its stake in Colgate-Palmolive by 0.6% during the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock valued at $1,831,000 after purchasing an additional 122 shares in the last quarter. Finally, DGS Capital Management LLC increased its position in shares of Colgate-Palmolive by 4.4% during the 4th quarter. DGS Capital Management LLC now owns 9,001 shares of the company’s stock valued at $818,000 after purchasing an additional 376 shares during the period. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Price Performance
Shares of NYSE:CL opened at $91.19 on Tuesday. The business has a fifty day simple moving average of $91.81 and a 200 day simple moving average of $97.45. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30. The firm has a market cap of $74.50 billion, a price-to-earnings ratio of 26.13, a P/E/G ratio of 3.59 and a beta of 0.44.
Colgate-Palmolive Dividend Announcement
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the company. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. UBS Group reduced their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. Stifel Nicolaus reduced their target price on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. Finally, StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $101.11.
Read Our Latest Research Report on CL
Insider Buying and Selling
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.34% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- What Does Downgrade Mean in Investing?
- Sizing Up a New Opportunity for NVIDIA Investors
- What is a Stock Market Index and How Do You Use Them?
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Following Congress Stock Trades
- The 3 Biggest M&A Stock Opportunities for 2025
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.